Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The First Brazilian Cardiovascular Registry of Atrial Fibrillation: Primary Results of the RECALL Study.
Lopes RD, de Barros E Silva PGM, Filho CRH, Cavalvante MA, Miranda CM, Esper RB, de Lima GG, Ritt LEF, da Silva RMFL, Nakazone MA, Almeida AP, Pavanello R, de Lima CEB, Backes LM, Oliveira LH, de Souza OF, Filho AML, God EMG, Jorge JCM, de Almeida Luiz A, Martins SFPP, Dantas RC, D Oliveira Vieira R, Zimerman LI, Júnior ÁRA, de Oliveira Figueiredo MJ, do Carmo Gomes SP, de Lima LM, Damiani LP, Teixeira RA, Fagundes AA, Saad EB; RECALL Investigators. Lopes RD, et al. Among authors: jorge jcm. Am Heart J. 2023 Oct;264:97-105. doi: 10.1016/j.ahj.2023.06.007. Epub 2023 Jun 15. Am Heart J. 2023. PMID: 37330162
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.
Lip GYH, Kotalczyk A, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Rothman KJ, Marler S, Gurusamy VK, Huisman MV; GLORIA-AF Investigators. Lip GYH, et al. Clin Res Cardiol. 2022 May;111(5):593. doi: 10.1007/s00392-022-02021-2. Clin Res Cardiol. 2022. PMID: 35384487 Free PMC article. No abstract available.
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide.
Haas S, Camm JA, Harald D, Steffel J, Virdone S, Pieper K, Brodmann M, Schellong S, Misselwitz F, Kayani G, Kakkar AK; GARFIELD-AF Investigators. Haas S, et al. Clin Res Cardiol. 2023 Jun;112(6):759-771. doi: 10.1007/s00392-022-02079-y. Epub 2022 Sep 12. Clin Res Cardiol. 2023. PMID: 36094573
[Guideline of atrial fibrillation].
Martinelli Filho M, Moreira DA, Lorga AM, Sosa E, Atié J, Pimenta J, Andrade JC, Fagundes ML, Kuniyoshi RR, Lorga Filho A, Lopes AN, Paola AA, Costa AB, Péres AK, Grupi CJ, Halperin C, Sternick E, Cruz FE, Darrieux FC, Lima GG, Jorge JC, Mateos JC, Oliveira JC, Zimerman LI, Scanavacca MI, Medeiros Pde T, Miranda RC, Costa R, Rassi SG, Galvão Filho SS, Tamer NS, Rodrigues Tda R. Martinelli Filho M, et al. Arq Bras Cardiol. 2003 Nov;81 Suppl 6:3-24. Arq Bras Cardiol. 2003. PMID: 15108640 Portuguese. No abstract available.
Edoxaban versus warfarin in patients with atrial fibrillation.
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators. Giugliano RP, et al. N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19. N Engl J Med. 2013. PMID: 24251359 Free article. Clinical Trial.
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry.
Ding WY, Fawzy AM, Romiti GF, Proietti M, Pastori D, Huisman MV, Lip GYH; GLORIA-AF Investigators. Ding WY, et al. J Thromb Thrombolysis. 2024 Jan;57(1):39-49. doi: 10.1007/s11239-023-02866-y. Epub 2023 Aug 11. J Thromb Thrombolysis. 2024. PMID: 37566295 Free PMC article.
16 results